Companies / Anika Therapeutics, Inc.

Anika Therapeutics, Inc.

Nasdaq: ANIKCIK 898437BEDFORD, MA

Financials · FY2025

Revenue$112.82M
Net income$-10.88M
Total debt$25.00M
Cash$38.41M
Diluted EPS$-0.76
Shares outstanding13.4M

Ownership

13.4M shares outstanding · as of Jul 24, 2026
3.7%Insiders
Ownership
Insiders3.68%492,671
Institutions90.85%12,158,142
Public float5.47%732,153

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
1.93%258,788
Colleran DavidEVP, General Counsel, Corp Sec
0.50%67,570
0.49%65,273
0.40%52,970
McLeod IanSVP, CAO & Treasurer
0.18%24,107
Griffin Stephen D.CEOPresident and CEO · Director
0.18%23,963

Institutional holders 129

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 14, 2026Blanchard Cheryl R
Director
OtherCommon Stock$209.1K-15K
-5.65%
245,761
1.84% of shares
low
Mar 15, 2026Blanchard Cheryl R
Director
OtherCommon Stock$171.9K-12K
-4.47%
258,788
1.93% of shares
low
Mar 9, 2026Blanchard Cheryl R
Director
OtherCommon Stock$87.8K-6K
-2.70%
211,450
1.58% of shares
low
Mar 14, 2026Griffin Stephen D.
CEO
OtherCommon Stock$84.4K-6K
-19.87%
23,963
0.18% of shares
low
May 1, 2026Henneman John B III
Director
BuyCommon Stock$73.3K+5K
+10.03%
54,871
0.41% of shares
medium
Mar 14, 2026Colleran David
Executive
OtherCommon Stock$59.2K-4K
-6.20%
63,014
0.47% of shares
low
Mar 9, 2026Colleran David
Executive
OtherCommon Stock$28.7K-2K
-3.49%
53,100
0.40% of shares
low
Mar 15, 2026Colleran David
Executive
OtherCommon Stock$26.9K-2K
-2.73%
67,570
0.50% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
Trigran Investments, Inc.Passive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ANIK035255108